Non-Invasive Blood Phenylalanine Monitor
Award last edited on: 10/17/02

Sponsored Program
Awarding Agency
Total Award Amount
Award Phase
Solicitation Topic Code

Principal Investigator
Abdel-Halim Ghanem

Company Information

Aciont Inc

615 Arapeen Drive Suite #302B
Salt Lake City, UT 84108
   (801) 895-4089
Location: Single
Congr. District: 02
County: Salt Lake

Phase I

Contract Number: 1R43DK060308-01A1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
Phase I Amount
Phenylketonuria (PKU) is a genetic deficiency of phenylalanine hydroxylase (PAH). Without PAH, the patient with PKU cannot metabolize phenylalanine (PHE) to tyrosine. The resulting accumulation of PHE and the accumulation of phenylpyruvate by a secondary metabolic pathway in the patient's blood produce neuropathies including severe mental retardation, behavioral problems, schizophrenia, and tremors. PKU treatment is tailored to keep plasma PHE concentrations between 2 and 6 mg/dl through a low-PHE diet and frequent blood monitoring. The invasiveness of this monitoring exposes the patient to infection risk, hypodermophobia (especially in children), plus the inconvenience and expense of performing invasive procedures and mailing or delivering the sample to the treatment center. We propose developing and commercializing a novel non-invasive, in-home monitoring device that can sample PHE through the patient's skin and correlate extracted PHE to blood concentrations with a high degree of accuracy and reproducibility using ACiont's proprietary reverse iontophoretic process. During development, we will team up with a bioengineering firm to develop a PHE biosensor for real-time, quantitative analysis. When complete, our device will allow patients to: easily perform the test and obtain results in a home setting, reduce clinic visit frequency by allowing result communications with clinicians over the internet, get real-time data with which to tailor treatment, decrease overall treatment costs through increased efficiency and elimination of third party laboratories, and drastically improve their control over PKU.

Thesaurus Terms:
biomedical equipment development, blood chemistry, monitoring device, noninvasive diagnosis, phenylalanine, phenylketonuria biosensor, portable biomedical equipment, skin bioengineering /biomedical engineering, clinical research, human subject

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
Phase II Amount